Expression of KID syndromic mutation Cx26S17F produces hyperactive hemichannels in supporting cells of the organ of Corti

Front Cell Dev Biol. 2023 Jan 9:10:1071202. doi: 10.3389/fcell.2022.1071202. eCollection 2022.

Abstract

Some mutations in gap junction protein Connexin 26 (Cx26) lead to syndromic deafness, where hearing impairment is associated with skin disease, like in Keratitis Ichthyosis Deafness (KID) syndrome. This condition has been linked to hyperactivity of connexin hemichannels but this has never been demonstrated in cochlear tissue. Moreover, some KID mutants, like Cx26S17F, form hyperactive HCs only when co-expressed with other wild-type connexins. In this work, we evaluated the functional consequences of expressing a KID syndromic mutation, Cx26S17F, in the transgenic mouse cochlea and whether co-expression of Cx26S17F and Cx30 leads to the formation of hyperactive HCs. Indeed, we found that cochlear explants from a constitutive knock-in Cx26S17F mouse or conditional in vitro cochlear expression of Cx26S17F produces hyperactive HCs in supporting cells of the organ of Corti. These conditions also produce loss of hair cells stereocilia. In supporting cells, we found high co-localization between Cx26S17F and Cx30. The functional properties of HCs formed in cells co-expressing Cx26S17F and Cx30 were also studied in oocytes and HeLa cells. Under the recording conditions used in this study Cx26S17F did not form functional HCs and GJCs, but cells co-expressing Cx26S17F and Cx30 present hyperactive HCs insensitive to HCs blockers, Ca2+ and La3+, resulting in more Ca2+ influx and cellular damage. Molecular dynamic analysis of putative heteromeric HC formed by Cx26S17F and Cx30 presents alterations in extracellular Ca2+ binding sites. These results support that in KID syndrome, hyperactive HCs are formed by the interaction between Cx26S17F and Cx30 in supporting cells probably causing damage to hair cells associated to deafness.

Keywords: cochlea; connexin; gap junction; hemichannel; organ of Corti; syndromic deafness.

Grants and funding

This research was funded by the ANID (ex Comisión Nacional Científica y Tecnológica, CONICT) fellowship and Beca de Gastos operacionales (to ACA), Fondecyt de Iniciación 11180531 (to IEG), Fondo Nacional de Desarrollo Científico y Tecnológico (FONDECYT-ANID) grants 1171240 (to ADM), 1211045 (to TPA) and 1191329 (to JCS); Fondo Nacional de Investigación en Salud (FONIS-FONDEF SA18I0194; to HAS and ADM) and FONDEF ID21I10153 (to ADM). Centro BASAL Ciencia & Vida FB210008, Programa de Financiamiento Basal para Centros Cientificos y Tecnológicos de Excelencia de ANID (to TPA). ICM-ANID ACE210014 and the Chilean Millennium Centro Interdisciplinario de Neurociencia de Valparaíso grant P09-022F (to JCS, ADM and HAS).